A, Structural context of the ADAMTS7 HExxH to HQxxH catalytic mutation.
Crystal structures from ADAMTS4 WT (PDB:4WKI)33 and ADAMTS4 EQ (PDB: 2RJP)34 were aligned and annotated in
PyMOL to highlight the catalytic residues and visualize the Zinc metal in the
active site. The E to Q substitution preserves the tertiary structure of ADAMTS4
and the residues “VAHELGH” in the active
site are conserved in ADAMTS7. B, Schematic of the Adamts7
E373Q catalytic mutant allele within exon 7. To generate the mutant allele, c.
1117G->C (p. E373Q) mutation at the Adamts7 catalytic
domain and c. 1113C->T (p. A371A) to disrupt the PAM site were induced by
CRISPR Homology-Directed Repair (HDR). C, Sanger sequencing of genomic tail DNA
PCR and heart mRNA RT-PCR from WT and heterozygous +/E373Q mice. Representative
forward reads show no evidence of allelic expression imbalance at the two
nucleotide substitutions. D, Adamts7 mRNA expression level in
the heart from WT, Adamts7 −/− (KO) and
homozygous E373Q/E373Q (EQ/EQ) mice were measured by real time quantitative
polymerase chain reaction (qPCR) using 2 TaqMan probe sets (exon 4–5
boundary and exon 23–24 boundary). n=4 per group. E,
Adamts12 mRNA expression levels were analyzed by real time
qPCR in the heart and aorta harvested from WT, KO and EQ/EQ mice. n=4 per group.
A Kruskal-Wallis test with Dunn’s multiple comparison test was applied to
D and E.